GLP- SM1 5mg SEMA

Semaglutide peptide is a long-acting GLP-1 receptor agonist used in approved prescription medicines for type 2 diabetes, chronic weight management, and certain cardiovascular risk-reduction indications, depending on the product label. People search for it because clinical trials show effects on blood sugar, appetite, body weight, and cardiovascular outcomes in defined populations. Safety matters: semaglutide can cause gastrointestinal side effects and has important warnings, contraindications, interaction concerns, and regulatory cautions, especially around compounded or unapproved products